Mitomycin 40 mg/80mL (Mitomycin INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION) 40 mg/80mL

Mitomycin 40 mg/80mL is a lyophilized powder for solution, used for intravenous administration. This medication is commonly associated with certain types of cancer treatments. Learn more about its uses and effects.

Strength

40 mg/80mL

Pack Size

1 VIAL in 1 CARTON (25021-252-51) / 80 mL in 1 VIAL

Manufacturer / TM Owner

Sagent Pharmaceuticals

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Mitomycin 40 mg/80mL is primarily used in the treatment of various types of cancer. It works by interfering with the growth of cancer cells, making it a key component in chemotherapy regimens. Patients often wonder, 'What is Mitomycin used for?' It is typically administered intravenously to target and slow the progression of malignant cells.

Side Effects

Common effects of Mitomycin may include nausea, vomiting, and fatigue. Some patients may experience hair loss or changes in blood cell counts. These effects can vary widely among individuals and are generally managed under medical supervision.

Precautions & Warnings

Mitomycin should be handled with care, as it is a potent medication. It is important to follow proper storage and administration guidelines to ensure safety. Patients should discuss any pre-existing conditions or allergies with their healthcare provider before use.

Avoid Interactions

Mitomycin may interact with other medications, including certain antibiotics and immunosuppressants. It is crucial to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and other substances may also affect the efficacy and safety of Mitomycin.

Frequently Asked Questions

Mitomycin is commonly used in the treatment of various types of cancer, particularly in chemotherapy regimens.

Mitomycin is administered intravenously as a lyophilized powder that is reconstituted into a solution.

Common side effects may include nausea, vomiting, fatigue, and hair loss. These effects can vary among individuals.

Mitomycin may interact with other medications, so it is important to consult a healthcare provider before combining treatments.

Mitomycin should be stored according to the manufacturer's guidelines to maintain its potency and safety.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.